Why the study?
Does disopyramide reduce echocardiographic and hemodynamic signs of left ventricular outflow obstruction in patients with muscular subaortic stenosis?
Population
Patients with muscular subaortic stenosis (hypertrophic cardiomyopathy)
Design
Editorial
Authors
Loading...
This editorial raises the question of whether true left ventricular outflow obstruction exists in hypertrophic cardiomyopathy, based on preliminary evidence of disopyramide's hemodynamic benefits.
Does disopyramide reduce echocardiographic and hemodynamic signs of left ventricular outflow obstruction in patients with muscular subaortic stenosis?
This editorial raises the question of whether true left ventricular outflow obstruction exists in hypertrophic cardiomyopathy, based on preliminary evidence of disopyramide's hemodynamic benefits.
Joseph P. Murgo (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: